NImmune Biopharma Announces Presentations at Digestive Disease Week 2026 Supporting a Differentiated Profile and Superior Efficacy of Oral, Once-Daily NIM-1324 for IBD
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNYSE
ABBV
AbbVie Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2012
Get push alerts for ABBV
Full ABBV profile on Quantisnow Follow ABBV and get a push notification the moment its next story breaks.